Velesco Pharma has expanded its capabilities for materials management with a new lab at its Plymouth, MI, facility, for the storage, dispensing, inventory management and distribution of non-GMP materials such as API, intermediates and compounds transitioning into development.
 
The company also provides analysis and formulation services to support compound management activities. The new lab space allows the company to provide compound management services for materials with either cGMP or non-GMP requirements. These services include long- and short-term storage of materials at ambient, refrigerated or frozen temperatures as well as material aliquoting over a wide weight range, along with labeling and distribution.
 
“Our newly expanded materials management laboratory is well suited to meet our client’s increasing need for the storage, analysis and the handling of compounds in the early stage of development,” said Dave Barnes, Ph.D., chief executive officer at Velesco. “We look forward to collaborating with our clients to efficiently provide the quality services to which they have become accustomed.”